Rani Therapeutics Holdings (RANI) Other Non-Current Assets (2022 - 2026)
Rani Therapeutics Holdings' (RANI) quarterly Other Non-Current Assets came in at $246000.0 in Q1 2026, little changed year-on-year from $246000.0 in Q1 2025, and little changed quarter-over-quarter from $246000.0 in Q4 2025.
Rani Therapeutics Holdings (RANI) Other Non-Current Assets (2022 - 2026) Analysis & Trends
Rani Therapeutics Holdings' Other Non-Current Assets history runs 5 years deep, the most recent figure standing at $246000.0 for Q1 2026.
- On a quarterly basis, Other Non-Current Assets changed 0.0% year-over-year to $246000.0 in Q1 2026; TTM through Mar 2026 was $246000.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at $246000.0, changed 0.0% from the prior year.
- Other Non-Current Assets held at $246000.0 in Q1 2026 per RANI's latest filing, from $246000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $500000.0 in Q3 2022 and bottomed at $245000.0 in Q3 2025.
- The 5-year median for Other Non-Current Assets is $246000.0 (2023), against an average of $273272.7.
- Biggest YoY gain for Other Non-Current Assets was 19.11% in 2025; the steepest drop was 0.41% in 2025.
- Year by year, Other Non-Current Assets stood at $500000.0 in 2022, then sank by 50.8% to $246000.0 in 2023, then changed by 0.0% to $246000.0 in 2024, then changed by 0.0% to $246000.0 in 2025, then changed by 0.0% to $246000.0 in 2026.
- Per Business Quant, the three latest RANI Other Non-Current Assets figures stand at $246000.0 (Q1 2026), $246000.0 (Q4 2025), and $245000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Rani Therapeutics Holdings | 160.20 Mn | 167.33 Mn | - | 246,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 246,000.00 |
| Dec 31, 2025 | 246,000.00 |
| Sep 30, 2025 | 245,000.00 |
| Jun 30, 2025 | 293,000.00 |
| Mar 31, 2025 | 246,000.00 |
| Dec 31, 2024 | 246,000.00 |
| Sep 30, 2024 | 246,000.00 |
| Jun 30, 2024 | 246,000.00 |
| Mar 31, 2024 | 246,000.00 |
| Dec 31, 2023 | 246,000.00 |
| Sep 30, 2022 | 500,000.00 |